Dr. Davies is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
240 E 38th St
19th Floor ACC
New York, NY 10016- Is this information wrong?
Education & Training
The University of Wales College of MedicineClass of 1992
Certifications & Licensure
NY State Medical License 2021 - 2024
AR State Medical License 2014 - 2019
Clinical Trials
- UARK 2014-21 A Phase II Trial of Oncolytic Virotherapy by Systemic Administration of Edmonston Strain of Measles Virus Start of enrollment: 2015 Mar 01
- 2015-09: A Phase II Randomized, Open-label Study of Anti-signaling Lymphocytic Activation Molecule Monoclonal Antibody During Maintenance Therapy Start of enrollment: 2017 May 01
- 2015-12: A Study Exploring the Use of Early and Late Consolidation/Maintenance Therapy Start of enrollment: 2017 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- Genomic Classification and Individualized Prognosis in Multiple Myeloma.Durante, M. A., Francesco Maura, Arjun Raj Rajanna, Bachisio Ziccheddu, Alexandra M Poos, Andriy Derkach, Kylee Maclachlan, Michael Durante, Benjamin Diamond, Marios P...> ;Journal of Clinical Oncology. 2024 Apr 10
- Advanced practice providers in hematology: actionable findings from national paired APP and physician surveys.Ariela L Marshall, Leah E Masselink, Peter A Kouides, Faith E Davies, Azam Farooqui, Srikanth Nagalla, Alex Herrera, Nicole Mortier, Robert Brodsky, Clese E Erikson> ;Blood Advances. 2024 Mar 12
- Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple Myeloma.Ghobrial, I., Gormley, N., Kumar, S., Mateos, M., Bergsagel, P., Chesi, M., Dhodapkar, M., Dispenzieri, A., Fonseca, R., Getz, G., Kastritis, E., Kristinsson, S., Mart...> ;Blood Cancer Discovery. 2024 Mar 4
- Join now to see all
Journal Articles
- Sub-Clonal TP53 Copy Number Is Associated with Prognosis in Multiple MyelomaFaith Davies, MD, Blood
- Characterisation of Immunoparesis in Newly Diagnosed Myeloma and Its Impact on Progression-Free and Overall Survival in Both Old and Recent Myeloma TrialsFaith Davies, MD, Nature
Abstracts/Posters
- Long-Term Outcome of Total Therapy Regimens: Impact of Molecular SubgroupsFaith E. Davies, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- EARLY Results of TOTAL Therapy 7 (TT7): High Response Rates of NEWLY Diagnosed High Risk Myeloma to DaratumumabFaith E. Davies, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Closing the Efficacy and Effectiveness Gap: Outcomes in Relapsed/Refractory Multiple Myeloma (RRMM) Patients (Pts) Treated with Ixazomib-Lenalidomide-Dexamethasone (IR...Faith E. Davies, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Lectures
- Current Obstacles in Myeloma Management: Debating the Evidence61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Baseline and on-Treatment Bone Marrow Microenvironments Predict Myeloma Patient Outcomes and Inform Potential Intervention Strategies2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Extracting Prognostic Molecular Information from PET-CT Imaging of Multiple Myeloma Using Radiomic Approaches2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
Clinical Challenges: Staying up to Date on Immunotherapy in Multiple MyelomaJanuary 4th, 2022
Leading Myeloma Experts to Join New Center for Blood Cancers at NYU Langone HealthApril 4th, 2019
Could a Unique MRI Scan Improve Treatments for Bone Marrow Cancer?February 12th, 2016- Join now to see all
Hospital Affiliations
NYU Langone HospitalsNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
